Literature DB >> 31259625

Chronic TGF-β1 Signaling in Pulmonary Arterial Hypertension Induces Sustained Canonical Smad3 Pathways in Vascular Smooth Muscle Cells.

Laurent Calvier1, Philippe Chouvarine1, Ekaterina Legchenko1, Gabor Kokeny2, Miklos M Mozes2, Georg Hansmann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31259625     DOI： 10.1165/rcmb.2018-0275LE

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN： 1044-1549            Impact factor:   6.914


× No keyword cloud information.
  7 in total

1.  Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019.

Authors:  Elena A Goncharova; Stephen Y Chan; Corey E Ventetuolo; Norbert Weissmann; Ralph T Schermuly; Christopher J Mullin; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2020-07-01       Impact factor: 21.405

2.  Apolipoprotein E receptor 2 deficiency decreases endothelial adhesion of monocytes and protects against autoimmune encephalomyelitis.

Authors:  Laurent Calvier; Navid Manouchehri; Anastasia Sacharidou; Chieko Mineo; Philip W Shaul; David Y Hui; Maria Z Kounnas; Olaf Stüve; Joachim Herz
Journal:  Sci Immunol       Date:  2021-08-27

3.  Reelin Depletion Protects Against Atherosclerosis by Decreasing Vascular Adhesion of Leukocytes.

Authors:  Laurent Calvier; Xunde Xian; Richard G Lee; Anastasia Sacharidou; Chieko Mineo; Philip W Shaul; Maria Z Kounnas; Shirling Tsai; Joachim Herz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-02-25       Impact factor: 10.514

Review 4.  Cellular mechanosignaling in pulmonary arterial hypertension.

Authors:  Ariel Wang; Daniela Valdez-Jasso
Journal:  Biophys Rev       Date:  2021-09-02

5.  Text Mining-Based Drug Discovery for Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.

Authors:  Jiang-Shan Tan; Song Hu; Ting-Ting Guo; Lu Hua; Xiao-Jian Wang
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

Review 6.  Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension.

Authors:  Laurent Calvier; Joachim Herz; Georg Hansmann
Journal:  JACC Basic Transl Sci       Date:  2022-02-28

7.  Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension.

Authors:  Sachindra R Joshi; Jun Liu; Troy Bloom; Elif Karaca Atabay; Tzu-Hsing Kuo; Michael Lee; Elitza Belcheva; Matthew Spaits; Rosa Grenha; Michelle C Maguire; Jeffrey L Frost; Kathryn Wang; Steven D Briscoe; Mark J Alexander; Brantley R Herrin; Roselyne Castonguay; R Scott Pearsall; Patrick Andre; Paul B Yu; Ravindra Kumar; Gang Li
Journal:  Sci Rep       Date:  2022-05-12       Impact factor: 4.996
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.